Clinical Research Directory
Browse clinical research sites, groups, and studies.
International Multicentric Retrospective Study on the Use of EV+P as First-line Therapy in Patients With la/mUC
Sponsor: Aron Research Foundation Ets
Summary
The ARON-2PLUS Study is designed as an International Multicentric Retrospective Study to collect global experiences with the use of Enfortumab vedotin plus Pembrolizumab as first-line therapy in patients with locally advanced/metastatic Urothelial Cancer. Two supplementary optional studies are designed: one is related to CT scans evaluation for 3D reconstruction analysis; the other one is an omic analysis on FFPE tissue.
Official title: International Multicentric Retrospective Study on the Use of Enfortumab Vedotin + Pembrolizumab as First-line Therapy in Patients With Locally Advanced/Metastatic Urothelial Cancer (ARON-2PLUS)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
361
Start Date
2026-02
Completion Date
2030-12
Last Updated
2026-02-19
Healthy Volunteers
No
Locations (1)
Ospedale di Macerata
Macerata, Italy